220
Participants
Start Date
December 31, 2007
Primary Completion Date
June 30, 2013
Study Completion Date
June 30, 2013
Early Treatment with HAART
HAART with possibility of de-intensification
No treatment
No treatment. For group 2, participants do not yet meet DHHS guidelines. For group 4, treatment is not initiated due to unwillingness or providers' expectation of poor adherence.
HAART Treatment - standard care
Initiation of HAART per DHHS guidelines, i.e. starting treatment and CD4+ T cells less than 350 cells/mm3 or HIV RNA \>100,000 copies/ml
Mount Sinai Medical Center, Manhattan
Montefiore Medical Center, The Bronx
Childrens Hospital of Philadelphia, Philadelphia
Childrens National Medical Center, Washington D.C.
Howard University - IMPAACT Site, Washington D.C.
University of Maryland, Baltimore
Johns Hopkins University - IMPAACT Site, Baltimore
University of Miami School of Medicine, Miami
Children's Diagnostic and Treatment Center, Fort Lauderdale
University of South Florida, Tampa
St. Jude Children's Research Center, Memphis
St. Jude Children's Research Hospital - IMPAACT Site, Memphis
Children's Hospital of Michigan - IMPAACT Site, Detroit
Stroger Hospital of Cook County, Chicago
Childrens Memorial Hospital, Chicago
Tulane University Health Sciences Center, New Orleans
Children's Hospital of Denver - IMPAACT Site, Aurora
Children's Hopsital of Los Angeles, Los Angeles
University of Southern California - IMPAACT Site, Los Angeles
University of California at San Francisco, San Francisco
University of Puerto Rico, San Juan
National Institute on Drug Abuse (NIDA)
NIH
National Institute of Mental Health (NIMH)
NIH
University of North Carolina, Chapel Hill
OTHER